INR 161.8
(0.09%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -86.36 Million | -22.08 Million | -22.66 Million | 8.65 Million | 168.95 Million | 64.67 Million |
Net Income | 3.46 Billion | 31.22 Million | 19.26 Million | 321.35 Million | 137.13 Million | 99.34 Million |
Depreciation & Amortization | 404 Thousand | 404 Thousand | 365 Thousand | 325 Thousand | 295 Thousand | 450 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -184.71 Million | -64.89 Million | -34.56 Million | -29.39 Million | 43.47 Million | 22.17 Million |
Other non-cash items | -3.36 Billion | 11.18 Million | -7.73 Million | -283.63 Million | -11.94 Million | -57.29 Million |
Investing Cash Flow | 60.6 Million | 1.69 Million | 5.59 Million | -68 Thousand | -119.32 Million | -24.16 Million |
Investments in PPE | - | -66 Thousand | -227 Thousand | -67 Thousand | -969 Thousand | -27 Thousand |
Acquisitions | 427 Thousand | - | - | - | 13.63 Million | 27 Thousand |
Investment purchases | -24.55 Million | - | -2000.00 | -1000.00 | -135.43 Million | -31.12 Million |
Sales/Maturities of investments | 84.72 Million | - | - | - | 3.44 Million | 4.59 Million |
Other Investing Activities | 62.88 Million | 1.75 Million | 5.82 Million | -1000.00 | 2000.00 | 2.37 Million |
Financing Cash Flow | 1.03 Million | 6.57 Million | 12.07 Million | 5.68 Million | -60.01 Million | -9.55 Million |
Debt repayment | -1.03 Million | -774 Thousand | - | - | - | - |
Dividends payments | -6000.00 | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 6000.00 | 7.35 Million | 12.07 Million | 5.68 Million | -60.01 Million | -9.55 Million |
Accounts receivables | -753 Thousand | 626 Thousand | -140 Thousand | 384 Thousand | 4.26 Million | -2.44 Million |
Accounts payables | 82 Thousand | -477 Thousand | 827 Thousand | -754 Thousand | -789 Thousand | 240 Thousand |
Inventory | - | 54.31 Million | 1000.00 | - | - | - |
Other working capital | -184.04 Million | -119.36 Million | -35.25 Million | -29.02 Million | 39.99 Million | 24.38 Million |
Cash at beginning of period | 32.49 Million | 49.5 Million | 54.5 Million | 40.23 Million | 50.61 Million | 19.65 Million |
Cash at end of period | 7.77 Million | 35.68 Million | 49.5 Million | 54.5 Million | 40.23 Million | 50.61 Million |
Capital Expenditure | - | -66 Thousand | -227 Thousand | -67 Thousand | -969 Thousand | -27 Thousand |
Effect of forex changes on cash | - | -3.19 Million | - | - | - | - |
Net cash flow / Change in cash | -24.72 Million | -13.81 Million | -4.99 Million | 14.26 Million | -10.38 Million | 30.96 Million |
Free Cash Flow | -86.36 Million | -22.15 Million | -22.89 Million | 8.58 Million | 167.98 Million | 64.64 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 120.25 Million | 4.35 Billion | 3.46 Billion | -897 Million | 24.23 Million | 3.82 Million |
Depreciation & Amortization | - | - | 404 Thousand | 101 Thousand | 102 Thousand | 102 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -184.71 Million | - | - | - |
Other non-cash items | -120.25 Million | -4.35 Billion | -3.36 Billion | 897 Million | -24.23 Million | -3.82 Million |
Investing Cash Flow | - | - | 60.6 Million | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | 427 Thousand | - | - | - |
Investment purchases | - | - | -24.55 Million | - | - | - |
Sales/Maturities of investments | - | - | 84.72 Million | - | - | - |
Other Investing Activities | - | - | 62.88 Million | - | - | - |
Financing Cash Flow | - | - | 1.03 Million | - | - | - |
Debt repayment | - | - | -1.03 Million | - | - | - |
Dividends payments | - | - | -6000.00 | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | 6000.00 | - | - | - |
Accounts receivables | - | - | -753 Thousand | - | - | - |
Accounts payables | - | - | 82 Thousand | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | -184.04 Million | - | - | - |
Cash at beginning of period | - | - | 32.49 Million | 32.77 Million | 32.56 Million | 32.49 Million |
Cash at end of period | - | - | 7.77 Million | 32.97 Million | 32.77 Million | 32.7 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -24.72 Million | 202 Thousand | 204 Thousand | 204 Thousand |
Free Cash Flow | - | - | -86.36 Million | 202 Thousand | 204 Thousand | 204 Thousand |
DRMA
6349
JOHNPHARMA
SLHN
TRIDENT
ASMVF